Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) is a trending stock on Zacks.com, despite its recent -0.5% monthly return lagging the broader market and its industry. The company has consistently surpassed consensus estimates, with its last reported quarter revenue up 19.2% to $2.25 billion and EPS at $1.81, both exceeding expectations. Analysts project continued robust growth, forecasting current fiscal year EPS at $7.84 (+6.8% YoY) and revenue at $9.65 billion (+15.6% YoY), with even stronger estimates for the next fiscal year. While ISRG's Zacks Value Style Score of 'D' suggests a premium valuation relative to peers, its Zacks Rank #2 (Buy) indicates potential near-term outperformance.

Analysis

Intuitive Surgical (ISRG) presents a diverging picture of recent stock performance against strong underlying fundamentals. Despite its shares returning -0.5% over the past month, significantly lagging the S&P 500's +5% gain, the company's operational execution remains robust. In its last reported quarter, ISRG posted a 19.2% year-over-year revenue increase to $2.25 billion and an EPS of $1.81, representing positive surprises of 3.27% and 5.85% over consensus estimates, respectively. This performance is part of a consistent trend, with the company beating EPS estimates for four consecutive quarters. Looking ahead, consensus forecasts project sustained double-digit revenue growth, with estimates of +15.6% for the current fiscal year and +15.1% for the next. Earnings growth is also expected to accelerate from +6.8% this year to +15.5% in the next fiscal year. However, two key factors warrant consideration: consensus estimates have remained unchanged over the last 30 days, suggesting a lack of recent upward revisions, and the stock's valuation is at a premium, as indicated by a Zacks Value Style Score of 'D'.

Key Decisions for Investors

• Given the strong, sustained double-digit revenue growth and accelerating earnings projections for the next fiscal year, growth-oriented investors might consider the recent share price weakness an opportunity to initiate or add to positions.
• Investors should weigh the robust growth outlook against the stock's premium valuation, which could present a risk if growth fails to meet high expectations or in the event of a broader market correction.
• Monitor for any upward revisions to analyst earnings estimates, as the lack of change in the past 30 days suggests that continued stock outperformance will likely require the company to keep surprising to the upside.